Faron Pharmaceuticals - Innovative medical solutions (Part 2)

“The FDA have advised that CR + Durability of CR are the endpoints of interest for approval” (Slide no:8) Are there any predictable benchmarks for those figures from the FDA’s approval history?

4 Likes